Abaxis is a leader in the development and commercialization of leading-edge medical device and innovative technology and services that support best medical practices, enabling practitioners to respond to the health needs of their patients, while operating point of care, onsite diagnostics for human and animal health. Clint Severson, CEO/COB voted entrepreneur of the year by Forbes Magazine and voted as one of 200 best companies to work for.
Type
Public
HQ
Union City, US
Founded
1995
Size (employees)
549 (est)-5%
Website
abaxis.com
ABAXIS was founded in 1995 and is headquartered in Union City, US

ABAXIS Office Locations

ABAXIS has an office in Union City
Union City, US (HQ)
3240 Whipple Rd

ABAXIS Data and Metrics

ABAXIS Financial Metrics

ABAXIS's revenue was reported to be $227.2 m in FY, 2017 which is a 4% increase from the previous period.
USD

Revenue (FY, 2017)

227.2 m

Revenue growth (FY, 2016 - FY, 2017), %

4%

Gross profit (FY, 2017)

125.8 m

Gross profit margin (FY, 2017), %

55%

Net income (FY, 2017)

32.7 m

EBIT (FY, 2017)

44.5 m

Market capitalization (19-Jul-2017)

1.2 b

Closing share price (19-Jul-2017)

51

Cash (31-Mar-2017)

91.3 m
ABAXIS's current market capitalization is $1.2 b.
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

171.9 m202.6 m218.9 m227.2 m

Revenue growth, %

18%8%4%

Cost of goods sold

78.1 m93.6 m95.6 m101.4 m

Gross profit

93.8 m109 m123.3 m125.8 m

Gross profit Margin, %

55%54%56%55%

Sales and marketing expense

45.2 m

R&D expense

19.8 m

General and administrative expense

16.3 m

Operating expense total

62.3 m74.7 m76.9 m81.4 m

EBIT

20.8 m34.3 m46.3 m44.5 m

EBIT margin, %

12%17%21%20%

Interest income

994 k(1.3 m)793 k6.6 m

Income tax expense

9 m12.2 m16.1 m18.3 m

Net Income

14.2 m27.3 m31.6 m32.7 m
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

73.6 m107 m88.3 m91.3 m

Accounts Receivable

27.3 m29 m35.1 m504

Inventories

27 m36.2 m35.1 m39 m

Current Assets

165.4 m209.9 m212.2 m233.2 m

PP&E

27.2 m27.3 m26.8 m34.3 m

Total Assets

217 m269.1 m271.4 m305.6 m

Accounts Payable

6.1 m7.3 m7.3 m7.5 m

Current Liabilities

16.9 m41.3 m29.2 m33.4 m

Non-Current Liabilities

6.2 m7.6 m5.9 m6 m

Total Liabilities

23.1 m48.9 m35.1 m39.4 m

Retained Earnings

69.3 m87.6 m109.3 m130.3 m

Total Equity

193.9 m220.2 m236.3 m266.2 m

Financial Leverage

1.1 x1.2 x1.1 x1.1 x
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

14.2 m27.3 m31.6 m32.7 m

Depreciation and Amortization

7.4 m8.5 m6.7 m7.3 m

Inventories

(2.5 m)(10 m)74 k(8.2 m)

Accounts Payable

(2 m)116 k(443 k)238 k

Cash From Operating Activities

35.6 m36.4 m28.1 m33.2 m

Purchases of PP&E

(5.6 m)(6.1 m)(5.2 m)(10.2 m)

Cash From Investing Activities

(13.4 m)10.1 m(20.2 m)(15.9 m)

Dividends Paid

(9 m)(10 m)(11.7 m)

Cash From Financing Activities

(4 m)(11 m)(26.6 m)(13.6 m)

Income Taxes Paid

4.9 m15.9 m19.9 m16.9 m
USDY, 2017

Revenue/Employee

413.9 k

Financial Leverage

1.1 x

ABAXIS Operating Metrics

ABAXIS's Patent Applications was reported to be 80 in FY, 2016
FY, 2016

Patent Applications

80

ABAXIS Market Value History

ABAXIS Revenue Breakdown

ABAXIS Online and Social Media Presence

ABAXIS Company Life and Culture

You may also be interested in